28488766|t|Brief isoflurane anesthesia regulates striatal AKT-GSK3beta signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease.
28488766|a|Parkinson's disease (PD) is a progressive neurodegenerative movement disorder primarily affecting the nigrostriatal dopaminergic system. The link between heightened activity of glycogen synthase kinase 3beta (GSK3beta) and neurodegene-rative processes has encouraged investigation into the potential disease-modifying effects of novel GSK3beta inhibitors in experimental models of PD. Therefore, the intriguing ability of several anesthetics to readily inhibit GSK3beta within the cortex and hippocampus led us to investigate the effects of brief isoflurane anesthesia on striatal GSK3beta signaling in naive rats and in a rat model of early-stage PD. Deep but brief (20-min) isoflurane anesthesia exposure increased the phosphorylation of GSK3beta at the inhibitory Ser9 residue, and induced phosphorylation of AKTThr308 (protein kinase B; negative regulator of GSK3beta) in the striatum of naive rats and rats with unilateral striatal 6-hydroxydopamine (6-OHDA) lesion. The 6-OHDA protocol produced gradual functional deficiency within the nigrostriatal pathway, reflected as a preference for using the limb ipsilateral to the lesioned striatum at 2 weeks post 6-OHDA. Interestingly, such motor impairment was not observed in animals exposed to four consecutive isoflurane treatments (20-min anesthesia every 48 h; treatments started 7 days after 6-OHDA delivery). However, isoflurane had no effect on striatal or nigral tyrosine hydroxylase (a marker of dopaminergic neurons) protein levels. This brief report provides promising results regarding the therapeutic potential and neurobiological mechanisms of anesthetics in experimental models of PD and guides development of novel disease-modifying therapies.
28488766	6	16	isoflurane	Chemical	MESH:D007530
28488766	47	50	AKT	Gene	24185
28488766	51	59	GSK3beta	Gene	84027
28488766	86	100	motor deficits	Disease	MESH:D009461
28488766	106	109	rat	Species	10116
28488766	131	150	Parkinson's disease	Disease	MESH:D010300
28488766	152	171	Parkinson's disease	Disease	MESH:D010300
28488766	173	175	PD	Disease	MESH:D010300
28488766	194	229	neurodegenerative movement disorder	Disease	MESH:D019636
28488766	329	359	glycogen synthase kinase 3beta	Gene	84027
28488766	361	369	GSK3beta	Gene	84027
28488766	487	495	GSK3beta	Gene	84027
28488766	533	535	PD	Disease	MESH:D010300
28488766	613	621	GSK3beta	Gene	84027
28488766	699	709	isoflurane	Chemical	MESH:D007530
28488766	733	741	GSK3beta	Gene	84027
28488766	761	765	rats	Species	10116
28488766	775	778	rat	Species	10116
28488766	800	802	PD	Disease	MESH:D010300
28488766	828	838	isoflurane	Chemical	MESH:D007530
28488766	892	900	GSK3beta	Gene	84027
28488766	1015	1023	GSK3beta	Gene	84027
28488766	1050	1054	rats	Species	10116
28488766	1059	1063	rats	Species	10116
28488766	1089	1106	6-hydroxydopamine	Chemical	MESH:D016627
28488766	1108	1114	6-OHDA	Chemical	MESH:D016627
28488766	1128	1134	6-OHDA	Chemical	MESH:D016627
28488766	1315	1321	6-OHDA	Chemical	MESH:D016627
28488766	1343	1359	motor impairment	Disease	MESH:D000068079
28488766	1416	1426	isoflurane	Chemical	MESH:D007530
28488766	1501	1507	6-OHDA	Chemical	MESH:D016627
28488766	1528	1538	isoflurane	Chemical	MESH:D007530
28488766	1575	1595	tyrosine hydroxylase	Gene	25085
28488766	1800	1802	PD	Disease	MESH:D010300
28488766	Association	24185	84027
28488766	Positive_Correlation	MESH:D007530	84027
28488766	Association	MESH:D010300	84027
28488766	Association	MESH:D007530	24185
28488766	Negative_Correlation	MESH:D007530	MESH:D009461
28488766	Negative_Correlation	MESH:D007530	MESH:D010300
28488766	Positive_Correlation	MESH:D016627	MESH:D000068079
28488766	Association	MESH:D016627	84027
28488766	Association	MESH:D009461	84027

